# CDIB BioScience Ventures: portfolio, investments and team > CDIB BioScience Ventures is a growth equity based in United States. 12 investments on record, latest Jun 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/cdib-bioscience-ventures (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # CDIB BioScience Ventures No cheque observed since Jun 2015, after 12 earlier cheques, and the website is dead. Dormant Growth equity Series B Series A Series C Health Care Hospital Cheques on record **0%** of best year **0** **cheques in 12 months**, 12 on record Since the last cheque **4162** days **00** hrs **00** min **00** sec Median round **$30M** Rounds led **0 of 12** Sole investor **1 rounds** Exits **2 from the portfolio** Mostly in **United States, 100%** Pitch CDIB BioScience Ventures ## CDIB BioScience Ventures highlights - 01 12 rounds on record - 02 Mostly Series B and Series A: 67% of its rounds - 03 Sole investor in 1 rounds, median $4.9M - 04 2 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Health Care Hospital - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **12 appearances** - **2015** 1 round - **Jun** **[Zentera Systems](https://millionrounds.com/company/zentera-systems)** Series A · US **$4.9M** Sole investor - **2007** 2 rounds - **Mar** **[Epiphany](https://millionrounds.com/company/epiphany)** Series A · US · deals.venturebeat.com **$36M** With 1 other - **Jan** **[Proprius Pharmaceuticals](https://millionrounds.com/company/proprius-pharmaceuticals)** Series A · US **$11M** With 4 others - **2006** 3 rounds - **Dec** **[Aprima Medical Software](https://millionrounds.com/company/aprima-medical-software)** Series C · US **$6.8M** With 2 others - **Dec** **[Xanthus Pharmaceuticals](https://millionrounds.com/company/xanthus-pharmaceuticals)** Series B · US **$25M** With 9 others - **Nov** **[Elixir Pharmaceuticals](https://millionrounds.com/company/elixir-pharmaceuticals)** Series C · US · deals.venturebeat.com **$46M** With 7 others - **2005** 1 round - **Nov** **[Nanosys](https://millionrounds.com/company/nanosys)** Series D · US **$42M** With 15 others - **2004** 1 round - **Jun** **[Somaxon Pharmaceuticals](https://millionrounds.com/company/somaxon-pharmaceuticals)** Series B · US **$23M** With 5 others - **2003** 2 rounds - **Dec** **[Xanthus Pharmaceuticals](https://millionrounds.com/company/xanthus-pharmaceuticals)** Series B · US **$31M** With 10 others - **Apr** **[Nanosys](https://millionrounds.com/company/nanosys)** Series B · US **$30M** With 12 others - **2002** 1 round - **Dec** **[Targacept](https://millionrounds.com/company/targacept)** Series B · US **$46M** With 8 others - **2001** 1 round - **Nov** **[Accelight Networks](https://millionrounds.com/company/accelight-networks)** Venture · US **$60M** With 9 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **2 in all** **[Somaxon Pharmaceuticals](https://millionrounds.com/company/somaxon-pharmaceuticals)** Bought by Pernix Therapeutics **Undisclosed** Mar 2013 **[Xanthus Pharmaceuticals](https://millionrounds.com/company/xanthus-pharmaceuticals)** Bought by Antisoma **Undisclosed** May 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series B Series A Series C Median round joined **$30M** the round, not its cheque Alone, median **$4.9M** Led 0 of 12 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Jun 2015 - **Exits:** 2 from the portfolio Rounds by stage said on their site - Series B *5* - Series A *3* - Series C *2* - Series D *1* - Venture *1* Cheques by year Led Joined 2001 2015 Often in the room with - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 3 - [Venrock](https://millionrounds.com/fund/venrock) 3 - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2 - [CDP Capital Technology Ventures](https://millionrounds.com/fund/cdp-capital-technology-ventures) 2 - [China Development Industrial Bank (CDIB)](https://millionrounds.com/fund/china-development-industrial-bank-cdib) 2 - [Fog City Capital](https://millionrounds.com/fund/fog-city-capital) 2 **Pitching CDIB BioScience Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as CDIB BioScience Ventures. A count of rooms they were both in, not a relationship either has claimed. [**ARCH Venture Partners** VC firm **3** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Venrock** VC firm **3** rounds together](https://millionrounds.com/fund/venrock)[**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**CDP Capital Technology Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/cdp-capital-technology-ventures)[**China Development Industrial Bank (CDIB)** Growth equity **2** rounds together](https://millionrounds.com/fund/china-development-industrial-bank-cdib)[**Fog City Capital** VC firm **2** rounds together](https://millionrounds.com/fund/fog-city-capital)[**GeneChem** Growth equity **2** rounds together](https://millionrounds.com/fund/genechem)[**Gimv** Private equity **2** rounds together](https://millionrounds.com/fund/gimv)[**Hambrecht & Quist Capital Management** Growth equity **2** rounds together](https://millionrounds.com/fund/hambrecht-and-quist-capital-management)[**Harris & Harris Group** Growth equity **2** rounds together](https://millionrounds.com/fund/harris-and-harris-group)[**HealthCare Ventures** Growth equity **2** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**Lux Capital** VC firm **2** rounds together](https://millionrounds.com/fund/lux-capital) ## Quick answers about CDIB BioScience Ventures ### What does CDIB BioScience Ventures invest in? CDIB BioScience Ventures invests most often at Series B and Series A (67% of the rounds on record), in sectors such as Health Care and Hospital. ### How active is CDIB BioScience Ventures? 12 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015. ### How big are CDIB BioScience Ventures's cheques? The median round it joins is $30M. ### Does CDIB BioScience Ventures lead rounds? Rarely, if at all: none of its 12 investments on record names it as the lead. ### Where does CDIB BioScience Ventures invest? Most of the companies it backs are in the United States (100%). ### Is CDIB BioScience Ventures investing now? It looks quiet: no investment on record since Jun 2015. ### Who does CDIB BioScience Ventures invest alongside? Most often ARCH Venture Partners (3 rounds together), Venrock (3 rounds together) and Alexandria Real Estate Equities (2 rounds together). ### What kind of investor is CDIB BioScience Ventures? CDIB BioScience Ventures is a growth equity firm based in United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=cdib-bioscience-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=cdib-bioscience-ventures)